Studies have shown that MELK could promote the progression of tumor cells by activating the PI3K/mTOR signaling pathway [18, 19], catalyzing the PDHc [25], and reprogramming the morphology and function of mitochondria [23]. The gene discussed is MELK; the disease is neoplasm.